Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H21N3O |
Molecular Weight | 319.4002 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC=CN1CCC(C(N)=O)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=SQKXYSGRELMAAU-UHFFFAOYSA-N
InChI=1S/C20H21N3O/c1-16-22-13-15-23(16)14-12-20(19(21)24,17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-11,13,15H,12,14H2,1H3,(H2,21,24)
Molecular Formula | C20H21N3O |
Molecular Weight | 319.4002 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:10:16 UTC 2023
by
admin
on
Fri Dec 15 17:10:16 UTC 2023
|
Record UNII |
XJR8Y07LJO
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4902
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
m11873
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
C120953
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
DB09262
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
DTXSID00870104
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
XJR8Y07LJO
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
C83789
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
6433090
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
170105-16-5
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
IMIDAFENACIN
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
8402
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
100000124434
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
CHEMBL53366
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY | |||
|
SUB32180
Created by
admin on Fri Dec 15 17:10:16 UTC 2023 , Edited by admin on Fri Dec 15 17:10:16 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
EXCRETED UNCHANGED |
URINE
|
||
|
TARGET -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
2h plasma
PLASMA
|
||
|
METABOLITE -> PARENT |
2h plasma
PLASMA
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
2h plasma
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||